PI
RXST icon

PEAK6 Investments’s RxSight RXST Stock Holding History

PEAK6 Investments’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$756K Buy
+15,300
New +$784K ﹤0.01% 2073
2024
Q2 		– Sell
-9,000
Closed -$464K – 4235
2024
Q1 		$464K Sell
9,000
-47,400
-84% -$2.33M ﹤0.01% 2497
2023
Q4 		$2.27M Buy
+56,400
New +$1.65M 0.01% 1414

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PEAK6 Investments's RXST Position: Q3 2024 in Review

PEAK6 Investments sold out of RxSight (RXST) in Q3 2024, closing a stake of 3,874 shares — an estimated $198K sold.

PEAK6 Investments first reported a position in RXST in Q2 2024 and held it in 1 quarter. The position peaked at $233K in Q2 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • PEAK6 Investments reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,874 RxSight shares in Q3 2024, an estimated $198K.
  • PEAK6 Investments first reported a position in RxSight in Q2 2024 and held it in 1 quarter.
  • PEAK6 Investments's RxSight position peaked at $233K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.